Till sidans topp

Sidansvarig: Webbredaktion
Sidan uppdaterades: 2012-09-11 15:12

Tipsa en vän
Utskriftsversion

Mature glycoprotein g pre… - Göteborgs universitet Till startsida
Webbkarta
Till innehåll Läs mer om hur kakor används på gu.se

Mature glycoprotein g presents high performance in diagnosing herpes simplex virus type 2 infection in sera of different tanzanian cohorts.

Artikel i vetenskaplig tidskrift
Författare Staffan Görander
Judica Mbwana
Eligius Lyamuya
Teresa Lagergård
Jan-Åke Liljeqvist
Publicerad i Clinical and vaccine immunology : CVI
Volym 13
Nummer/häfte 6
Sidor 633-9
ISSN 1556-6811
Publiceringsår 2006
Publicerad vid Institutionen för biomedicin, avdelningen för mikrobiologi och immunologi
Institutionen för biomedicin, avdelningen för infektionssjukdomar
Sidor 633-9
Språk en
Länkar dx.doi.org/10.1128/CVI.00051-06
Ämnesord Adolescent, Adult, Age Factors, Animals, Antibody Specificity, Blotting, Western, methods, Cells, Cultured, Cohort Studies, Enzyme-Linked Immunosorbent Assay, methods, Female, Herpes Genitalis, blood, diagnosis, epidemiology, immunology, Herpesvirus 2, Human, immunology, isolation & purification, Humans, Infection, Male, Middle Aged, Sensitivity and Specificity, Seroepidemiologic Studies, Sex Factors, Tanzania, epidemiology, Viral Envelope Proteins, classification, diagnostic use, immunology, isolation & purification
Ämneskategorier Medicin och Hälsovetenskap

Sammanfattning

Herpes simplex virus type 2 (HSV-2) is a common sexually transmitted infection in sub-Saharan Africa. Glycoprotein G (gG) of HSV-2 elicits a type-specific antibody response and is widely used for serodiagnosis. gG is cleaved into a secreted portion (sgG-2) and a highly O-glycosylated mature portion (mgG-2). The performances of these two native immunosorbent purified antigens were compared in an enzyme-linked immunosorbent assay (ELISA) format with a commercially available assay (FOCUS2) using sera from blood donors (n = 194) and individuals (n = 198) with genital ulcer disease (GUD) from Tanzania. Discordant results were resolved by Western blotting. The HSV-2 seroprevalence for blood donors was estimated as 42%, and that for the GUD cohort was estimated as 78%. The prevalence increased significantly with age for both cohorts and was higher among human immunodeficiency virus (HIV)-positive individuals than among HIV-negative subjects. In the GUD cohort with a high HSV-2 prevalence, all three assays showed statistically similar performances, with sensitivities between 97% and 99% and specificities in the range of 86% to 91%. In contrast, among blood donors with a lower seroprevalence, the mgG-2-based ELISA presented significantly higher specificity (97%) than the sgG-2 ELISA (89%) and FOCUS2 (74%). Overall, the mgG-2 ELISA gave a high performance, with negative and positive predictive values of 96% for blood donors and a negative predictive value of 95% and a positive predictive value of 97% for the GUD cohort. We conclude that native purified mgG-2 showed the highest accuracy for detection of HSV-2 in patient sera from Tanzania and is therefore suitable for seroprevalence studies as well as in clinical settings.

Sidansvarig: Webbredaktion|Sidan uppdaterades: 2012-09-11
Dela:

På Göteborgs universitet använder vi kakor (cookies) för att webbplatsen ska fungera på ett bra sätt för dig. Genom att surfa vidare godkänner du att vi använder kakor.  Vad är kakor?